NXTC Q4 2025 Earnings — NextCure, Inc. Revenue & Financial Results | Market Cap Arena

NXTCNextCure, Inc.

$36M

Q4 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$365,000

Operating Income

-$10M

Net Income

-$9M

EPS (Diluted)

$-2.69

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$435,000

Balance Sheet

Total Assets

$50M

Total Liabilities

$15M

Stockholders' Equity

$35M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$365,000	$0	—
Operating Income	-$10M	-$12M	+21.7%
Net Income	-$9M	-$12M	+18.7%